Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.


Demircan N., Dane F., Ozturk M. A., Babacan N. A., Besiroglu M., Kaya S., ...Daha Fazla

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.24, sa.4, ss.1494-1500, 2019 (SCI-Expanded, Scopus) identifier identifier identifier